Q&A: Brian Ward, president of Hemophilia and Bleeding Disorders of Alabama In each issue of HemAware , we take a look at how local NHF chapters and associations are making a... Read More Advocacy, Chapter Roundup FDA Recommends Screening Blood Products for Parvovirus B19 The US Food and Drug Administration (FDA) issued a recommendation in July 2009 that makers of plasma-derived products, which include... Read More Blood Safety Healthcare Reform Passes For the latest updates on the passage of healthcare reform, see the NHF Web site. See also: Hemophilia and Healthcare... Read More Advocacy The State of Healthcare Reform See also: NHF Community Meets with Congress. Read More Advocacy What's in the Data? A lot has changed in the more than 30 years since hemophilia treatment centers (HTCs) were started as a way... Read More Hemophilia A&B, Advocacy NHF Community Talks Healthcare Reform with Congress See also: Healthcare Reform Passes. Read More Advocacy Grasping the High Costs of Lifetime Insurance See also: Learn how to manage your health insurance lifetime limits. Read More Insurance Managing Your Health Insurance Lifetime Limits See also Lifetime Insurance Limits. Read More Insurance MASAC Addresses Mad Cow Disease A new recommendation by the National Hemophilia Foundation’s (NHF’s) Medical and Scientific Advisory Council (MASAC) addresses concerns of blood contamination... Read More Blood Safety Managing Medical Costs in a Down Economy This article addresses issues that primarily affect individuals with commercial (private) health insurance. We are facing tough economic times. Job... Read More Insurance Patient Assistance Programs Katherine Spacek has never had to use the patient assistance program offered by the manufacturer of the clotting factor used... Read More Taking Charge, Insurance Disability Income Insurance and Long-Term Care Insurance Information in this article comes from America’s Health Insurance Plans and the Wisconsin Office of the Commissioner of Insurance booklet... Read More Insurance Load More
